Rare diseases
Investigational molecules
Locations
Theodor-Stern-Kai 7, Sachsenhausen, 60596 Frankfurt, Germany
Goethe University Frankfurt in Frankfurt, Germany specialises in clinical trials of conditions such as Dermatitis atopic, Hidradenitis, Non-small cell lung cancer, Acute myeloid leukaemia, and other specialisations. This site conducts important research.
At the Epilepsy Center Frankfurt Rhine-Main, investigators are focusing on Tuberous Sclerosis Complex–related seizures, exploring new options to improve long‑term control for both children and adults.
The program underscores Goethe University Frankfurt’s commitment to advancing treatments for nervous system disorders.
Researchers are evaluating a precision approach for patients with H3 K27M‑mutant diffuse glioma, aiming to enhance outcomes after standard radiotherapy.
The study highlights the site’s expertise in neuro‑oncology within the broader neoplasm therapeutic area.
A novel immunotherapy trial is testing the CVGBM vaccine in patients who have undergone surgery for glioblastoma or astrocytoma, seeking to prevent tumor recurrence.
This effort reflects the center’s dedication to innovative cancer therapies within the neoplasms research portfolio.
Clinical trials currently enrolling participants at this site.
GermanyLong‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
GermanyPhase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer
GermanyLong-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
GermanyA study to evaluate the effectiveness and safety of lebrikizumab in adults with nummular eczema who do not respond well to topical corticosteroids.
GermanyA Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety
GermanyA Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis
GermanyStudy of BNT327 and a drug combination for patients with untreated metastatic or locally recurrent triple-negative breast cancer
GermanyA study testing molnupiravir in adults with COVID-19 who are not hospitalized and are at high risk for serious illness
GermanyLong-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis
GermanyA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
GermanyA study of navenibart for long-term safety in patients with hereditary angioedema
GermanyMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
